Recipient NameVladimir Lenchitsky
Recipient TitleFounder and Chairman of the Board
- Vitalab Pharmacy, Inc. dba Vasco Rx Specialty Pharmacy
4045 E. Bell Rd.
Phoenix, AZ 85032
- Issuing Office:
- Division of Pharmaceutical Quality Operations IV
Dear Mr. Lenchitsky :
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL# 570563) dated January 10, 2019. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
CDR Steven E Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV